Lapuk S, Mukhametzyanov T, Schick C, Gerasimov A. Kinetic stability of amorphous dipyridamole: A fast scanning calorimetry investigation. Int J Pharm. 2020;574:118890 pubmed publisher

Abt E, Rosser E, Durst M, Lok V, Poddar S, Le T, et al. Metabolic Modifier Screen Reveals Secondary Targets of Protein Kinase Inhibitors within Nucleotide Metabolism. Cell Chem Biol. 2020;27:197-205.e6 pubmed publisher

Huang B, Chen Z, Geng L, Wang J, Liang H, Cao Y, et al. Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways. Cell. 2019;179:1160-1176.e24 pubmed publisher

Yang D, Zhang Q, Ma Y, Che Z, Zhang W, Wu M, et al. Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis. EBioMedicine. 2019;47:114-127 pubmed publisher

Androschuk A, He R, Weber S, Rosenfelt C, Bolduc F. Stress Odorant Sensory Response Dysfunction in Drosophila Fragile X Syndrome Mutants. Front Mol Neurosci. 2018;11:242 pubmed publisher

Okwuosa T, Soares C, Gollwitzer V, Habashy R, Timmins P, Alhnan M. On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing. Eur J Pharm Sci. 2018;118:134-143 pubmed publisher

Chung E, Efstathiou N, Konstantinou E, Maidana D, Miller J, Young L, et al. AICAR suppresses TNF-α-induced complement factor B in RPE cells. Sci Rep. 2017;7:17651 pubmed publisher

Herington J, Swale D, Brown N, Shelton E, Choi H, Williams C, et al. High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility. PLoS ONE. 2015;10:e0143243 pubmed publisher

Eyer K, Root K, Verboket P, Dittrich P. Detection of Infertility-related Neutralizing Antibodies with a Cell-free Microfluidic Method. Sci Rep. 2015;5:16551 pubmed publisher

Thukkani A, Agrawal K, Prince L, Smoot K, Dufour A, Cho K, et al. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. J Am Coll Cardiol. 2015;66:1091-101 pubmed publisher

Grover P, Shi H, Baumgartner M, Camacho C, Smithgall T. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function. PLoS ONE. 2015;10:e0133590 pubmed publisher

Hinzman J, Gibson J, Tackla R, Costello M, Burmeister J, Quintero J, et al. Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays. Biosens Bioelectron. 2015;74:512-7 pubmed publisher

Morandi F, Horenstein A, Chillemi A, Quarona V, Chiesa S, Imperatori A, et al. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation. J Immunol. 2015;195:965-72 pubmed publisher

Otsuguro K, Tomonari Y, Otsuka S, Yamaguchi S, Kon Y, Ito S. An adenosine kinase inhibitor, ABT-702, inhibits spinal nociceptive transmission by adenosine release via equilibrative nucleoside transporters in rat. Neuropharmacology. 2015;97:160-70 pubmed publisher

Lim S, Coughlan C, Murphy S, Fernandez Cadenas I, Montaner J, Thijs V, et al. Platelet function testing in transient ischaemic attack and ischaemic stroke: A comprehensive systematic review of the literature. Platelets. 2015;26:402-12 pubmed publisher

Quan H, Kim J, Lee H, Lee S, Choi J, Bae H. AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase. PLoS ONE. 2015;10:e0127885 pubmed publisher

Alsharif K, Thomas M, Judge H, Khan H, Prince L, Sabroe I, et al. Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis. Vascul Pharmacol. 2015;71:201-7 pubmed publisher

Ohkawa R, Kurano M, Mishima Y, Nojiri T, Tokuhara Y, Kishimoto T, et al. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects. Clin Biochem. 2015;48:690-7 pubmed publisher

Del Ry S, Moscato S, Bianchi F, Morales M, Dolfi A, Burchielli S, et al. Altered expression of connexin 43 and related molecular partners in a pig model of left ventricular dysfunction with and without dipyrydamole therapy. Pharmacol Res. 2015;95-96:92-101 pubmed publisher

Sandgren P, Rönnmark J, Axelsson J. In vitro affinity reduction of biologic response modifiers from production buffy coat platelets exposed to recombinant protein receptors. Transfusion. 2015;55:1919-26 pubmed publisher

Hughes S, Cravetchi X, Vilas G, Hammond J. Adenosine A1 receptor activation modulates human equilibrative nucleoside transporter 1 (hENT1) activity via PKC-mediated phosphorylation of serine-281. Cell Signal. 2015;27:1008-18 pubmed publisher

Al Ali B, Holz M, Sadik P, Oppeck C, Schmidt K, Oppeck G. Correlation between erectile function and cardiovascular risk factors by assessing arterial stiffness and myocardial perfusion imaging and carotid artery intima-media thickness. Minerva Urol Nefrol. 2015;67:11-8 pubmed

Quan E, Wang H, Dong D, Zhang X, Wu B. Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide. Drug Metab Dispos. 2015;43:433-43 pubmed publisher

Siebel A, Menezes F, Capiotti K, Kist L, da Costa Schaefer I, Frantz J, et al. Role of adenosine signaling on pentylenetetrazole-induced seizures in zebrafish. Zebrafish. 2015;12:127-36 pubmed publisher

Liu X, Zheng Y, Li Y, Wu S, Zhen Y. A multifunctional drug combination shows highly potent therapeutic efficacy against human cancer xenografts in athymic mice. PLoS ONE. 2014;9:e115790 pubmed publisher

Okuda Y, Ishikura K, Hamada R, Harada R, Sakai T, Hamasaki Y, et al. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children. Nephrology (Carlton). 2015;20:286-92 pubmed publisher

Damaraju V, Kuzma M, Mowles D, Cass C, Sawyer M. Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy?. Mol Cancer Ther. 2015;14:236-45 pubmed publisher

Bone D, Antic M, Quinonez D, Hammond J. Hypoxanthine uptake by skeletal muscle microvascular endothelial cells from equilibrative nucleoside transporter 1 (ENT1)-null mice: effect of oxidative stress. Microvasc Res. 2015;98:16-22 pubmed publisher

Francois V, Shehade H, Acolty V, Preyat N, Delrée P, Moser M, et al. Intestinal immunopathology is associated with decreased CD73-generated adenosine during lethal infection. Mucosal Immunol. 2015;8:773-84 pubmed publisher

Kusek J, Yang Q, Witek M, Gruber C, Nanoff C, Freissmuth M. Chaperoning of the A1-adenosine receptor by endogenous adenosine - an extension of the retaliatory metabolite concept. Mol Pharmacol. 2015;87:39-51 pubmed publisher

Karmouty Quintana H, Philip K, Acero L, Chen N, Weng T, Molina J, et al. Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension. FASEB J. 2015;29:50-60 pubmed publisher

Sunderland J, Pan X, Declerck J, Menda Y. Dependency of cardiac rubidium-82 imaging quantitative measures on age, gender, vascular territory, and software in a cardiovascular normal population. J Nucl Cardiol. 2015;22:72-84 pubmed publisher

Nicolussi S, Chicca A, Rau M, Rihs S, Soeberdt M, Abels C, et al. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent. Biochem Pharmacol. 2014;92:669-89 pubmed publisher

Balakumar P, Varatharajan R, Nyo Y, Renushia R, Raaginey D, Oh A, et al. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats. Pharmacol Res. 2014;90:36-47 pubmed publisher

Goda A, Erikson R, Sakai T, Ahn J, Kim B. Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies. Mol Oncol. 2015;9:309-22 pubmed publisher

Morrison J, Nophsker M, Haskell R. A combination turbidity and supernatant microplate assay to rank-order the supersaturation limits of early drug candidates. J Pharm Sci. 2014;103:3022-32 pubmed publisher

Tang Y, Vital S, Russell J, Seifert H, Senchenkova E, Granger D. Transient ischemia elicits a sustained enhancement of thrombus development in the cerebral microvasculature: effects of anti-thrombotic therapy. Exp Neurol. 2014;261:417-23 pubmed publisher

Mitra A, Fadda H. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum. Mol Pharm. 2014;11:2835-44 pubmed publisher

Bone D, Antic M, Vilas G, Hammond J. Oxidative stress modulates nucleobase transport in microvascular endothelial cells. Microvasc Res. 2014;95:68-75 pubmed publisher

Wang X, Sawada T, Sawada O, Saishin Y, Liu P, Ohji M. Serum and plasma vascular endothelial growth factor concentrations before and after intravitreal injection of aflibercept or ranibizumab for age-related macular degeneration. Am J Ophthalmol. 2014;158:738-744.e1 pubmed publisher

Soares A, Costa V, Diniz C, Fresco P. Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways. Basic Clin Pharmacol Toxicol. 2015;116:25-36 pubmed publisher

Moriarity B, Rahrmann E, Beckmann D, Conboy C, Watson A, Carlson D, et al. Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PLoS ONE. 2014;9:e96114 pubmed publisher

Joseph E, Green P, Levine J. ATP release mechanisms of endothelial cell-mediated stimulus-dependent hyperalgesia. J Pain. 2014;15:771-7 pubmed publisher

Arimany Nardi C, Errasti Murugarren E, Minuesa G, Martinez Picado J, Gorboulev V, Koepsell H, et al. Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors. Br J Pharmacol. 2014;171:3868-80 pubmed publisher

Zecevic D, Meier R, Daniels R, Wagner K. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures. Eur J Pharm Biopharm. 2014;87:264-70 pubmed publisher

Placková P, Hrebabecký H, Sála M, Nencka R, Elbert T, Mertlíková Kaiserová H. Transport mechanisms of a novel antileukemic and antiviral compound 9-norbornyl-6-chloropurine. J Enzyme Inhib Med Chem. 2015;30:57-62 pubmed publisher

Hsieh Y, Box K, Taylor L. Assessing the impact of polymers on the pH-induced precipitation behavior of poorly water soluble compounds using synchrotron wide angle X-ray scattering. J Pharm Sci. 2014;103:2724-2735 pubmed publisher

Ramadan A, Naydenova Z, Stevanovic K, Rose J, Coe I. The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity. Purinergic Signal. 2014;10:305-12 pubmed publisher

Lee M, Saver J, Hong K, Rao N, Wu Y, Ovbiagele B. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med. 2013;159:463-70 pubmed publisher

Deva D, Torres F, Wald R, Roche S, Jiménez Juan L, Oechslin E, et al. The value of stress perfusion cardiovascular magnetic resonance imaging for patients referred from the adult congenital heart disease clinic: 5-year experience at the Toronto General Hospital. Cardiol Young. 2014;24:822-30 pubmed publisher

Wang C, Lin W, Playa H, Sun S, Cameron K, Buolamwini J. Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4). Biochem Pharmacol. 2013;86:1531-40 pubmed publisher

Cullis P, Watson D, Cameron A, McKee R. Dipyridamole and paracetamol overdose resulting in multi-organ failure. Scott Med J. 2013;58:e14-7 pubmed publisher

Douiri A, McKevitt C, Emmett E, Rudd A, Wolfe C. Long-term effects of secondary prevention on cognitive function in stroke patients. Circulation. 2013;128:1341-8 pubmed publisher

Liu Y, Oh S, Chang K, Kim Y, Lee M. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Biochem Pharmacol. 2013;86:914-25 pubmed publisher

Li X, Zhou G, Zhou X, Zhou S. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials. J Neurol Sci. 2013;332:92-6 pubmed publisher

Zuurbier S, Vermeer S, Hilkens P, Algra A, Roos Y. [Secondary prevention with clopidogrel after TIA or stroke]. Ned Tijdschr Geneeskd. 2013;157:A5836 pubmed

Zimmerman M, Tak E, Ehrentraut S, Kaplan M, Giebler A, Weng T, et al. Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion. Hepatology. 2013;58:1766-78 pubmed publisher

He W, Mazumder A, Wilder T, Cronstein B. Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma. FASEB J. 2013;27:3446-54 pubmed publisher

Madsen C, Andersen K, Zerahn B. High coronary artery calcium score affects clinical outcome despite normal stress myocardial perfusion imaging and normal left ventricular ejection fraction. Coron Artery Dis. 2013;24:142-7 pubmed publisher

Montenegro M, Sáez Ayala M, Piñero Madrona A, Cabezas Herrera J, Rodriguez Lopez J. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation. PLoS ONE. 2012;7:e52231 pubmed publisher

Massaro M, Scoditti E, Carluccio M, Pellegrino M, Calabriso N, Storelli C, et al. Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes. Thromb Haemost. 2013;109:280-9 pubmed publisher

Gaibazzi N, Rigo F, Lorenzoni V, Molinaro S, Bartolomucci F, Reverberi C, et al. Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography. JACC Cardiovasc Imaging. 2013;6:1-12 pubmed publisher

De Bruyne B, Penicka M. Coronary flow velocity reserve and survival. JACC Cardiovasc Imaging. 2012;5:1086-7 pubmed publisher

Cortigiani L, Rigo F, Gherardi S, Bovenzi F, Molinaro S, Picano E, et al. Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. JACC Cardiovasc Imaging. 2012;5:1079-85 pubmed publisher

Valentine N, van de Laar F, Van Driel M. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2012;11:CD005449 pubmed publisher

Wadiwala M, Kamal A. What is better antiplatelet agent to prevent recurrent stroke?. J Pak Med Assoc. 2012;62:976-7 pubmed

Karagkiozaki V, Vavoulidis E, Karagiannidis P, Gioti M, Fatouros D, Vizirianakis I, et al. Development of a nanoporous and multilayer drug-delivery platform for medical implants. Int J Nanomedicine. 2012;7:5327-38 pubmed publisher

Tobin W, Kinsella J, Kavanagh G, O Donnell J, McGrath R, Collins D, et al. Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2013;260:590-6 pubmed publisher

Virgilio A, Spano D, Esposito V, Di Dato V, Citarella G, Marino N, et al. Novel pyrimidopyrimidine derivatives for inhibition of cellular proliferation and motility induced by h-prune in breast cancer. Eur J Med Chem. 2012;57:41-50 pubmed publisher

Cortigiani L, Rigo F, Gherardi S, Bovenzi F, Molinaro S, Picano E, et al. Prognostic implication of Doppler echocardiographic derived coronary flow reserve in patients with left bundle branch block. Eur Heart J. 2013;34:364-73 pubmed publisher

Flemming K, Link M, Christianson T, Brown R. Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg. 2013;118:43-6 pubmed publisher

Vanstreels L, Molenberghs G, Voigt J. Secondary stroke prevention: misguided by guidelines?. Acta Cardiol. 2012;67:431-8 pubmed

Karaguzel E, Kutlu O, Yulug E, Mungan S, Kazaz I, Tok D, et al. Comparison of the protective effect of dipyridamole and acetylsalicylic acid on long-term histologic damage in a rat model of testicular ischemia-reperfusion injury. J Pediatr Surg. 2012;47:1716-23 pubmed publisher

Sampaio F, Castro P, Marques S, Campos P, Ferreira M, Andrade S. Genetic background determines inflammatory angiogenesis response to dipyridamole in mice. Exp Biol Med (Maywood). 2012;237:1084-92 pubmed

Brochot E, François C, Castelain S, Helle F, van Nhien A, Duchaussoy I, et al. A new tool to study ribavirin-induced haemolysis. Antivir Ther. 2012;17:1311-7 pubmed publisher

Caso V, Santalucia P, Acciarresi M, Pezzella F, Paciaroni M. Antiplatelet treatment in primary and secondary stroke prevention in women. Eur J Intern Med. 2012;23:580-5 pubmed publisher

Weber R, Brenck J, Diener H. Antiplatelet therapy in cerebrovascular disorders. Handb Exp Pharmacol. 2012;:519-46 pubmed publisher

Rondina M, Weyrich A. Targeting phosphodiesterases in anti-platelet therapy. Handb Exp Pharmacol. 2012;:225-38 pubmed publisher

Eisert W. Dipyridamole in antithrombotic treatment. Adv Cardiol. 2012;47:78-86 pubmed publisher

Hsieh P, Su H, Lo H, Chen M. Dipyridamole 201Tl myocardial SPECT in the assessment of a patient with myocardial bridging and concomitant atherosclerotic coronary artery disease. Clin Nucl Med. 2012;37:e257-62 pubmed publisher

Psachoulias D, Vertzoni M, Butler J, Busby D, Symillides M, Dressman J, et al. An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine. Pharm Res. 2012;29:3486-98 pubmed publisher

Jabbour A, Boshell D, Sesel K, Silverstone E, Muller D, Stirrup J, et al. Inducible myocardial ischaemia diagnosed using computed tomography dipyridamole stress myocardial perfusion technique. J Med Imaging Radiat Oncol. 2012;56:445-8 pubmed publisher

Dewilde S, Hawkins N. Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention. J Clin Epidemiol. 2012;65:835-45 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Iadevaia V, Zhang Z, Jan E, Proud C. mTOR signaling regulates the processing of pre-rRNA in human cells. Nucleic Acids Res. 2012;40:2527-39 pubmed publisher

Bland N, Wang C, Tallman C, Gustafson A, Wang Z, Ashton T, et al. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness. J Med Chem. 2011;54:8188-94 pubmed publisher

Street S, Walsh P, Sowa N, Taylor Blake B, Guillot T, Vihko P, et al. PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol Pain. 2011;7:80 pubmed publisher

Greenhalgh J, Bagust A, Boland A, Martín Saborido C, Oyee J, Blundell M, et al. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. Health Technol Assess. 2011;15:1-178 pubmed publisher

Beghyn T, Charton J, Leroux F, Laconde G, Bourin A, Cos P, et al. Drug to genome to drug: discovery of new antiplasmodial compounds. J Med Chem. 2011;54:3222-40 pubmed publisher

Saravanan K, Barlow H, Barton M, Calvert A, Golding B, Newell D, et al. Nucleoside transport inhibitors: structure-activity relationships for pyrimido[5,4-d]pyrimidine derivatives that potentiate pemetrexed cytotoxicity in the presence of α1-acid glycoprotein. J Med Chem. 2011;54:1847-59 pubmed publisher

Talevi A, Goodarzi M, Ortiz E, Duchowicz P, Bellera C, Pesce G, et al. Prediction of drug intestinal absorption by new linear and non-linear QSPR. Eur J Med Chem. 2011;46:218-28 pubmed publisher

Melani A, Cipriani S, Corti F, Pedata F. Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia. Ann N Y Acad Sci. 2010;1207:89-96 pubmed publisher

Pattillo C, Fang K, Terracciano J, Kevil C. Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses. Ann N Y Acad Sci. 2010;1207:83-8 pubmed publisher

d Esterre C, Lee T. Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits. Ann N Y Acad Sci. 2010;1207:71-5 pubmed publisher

Ekins S, Williams A, Xu J. A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug Metab Dispos. 2010;38:2302-8 pubmed publisher

Gozalbes R, Pineda Lucena A. QSAR-based solubility model for drug-like compounds. Bioorg Med Chem. 2010;18:7078-84 pubmed publisher

Greene N, Fisk L, Naven R, Note R, Patel M, Pelletier D. Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol. 2010;23:1215-22 pubmed publisher

Crown N, Mysak T. Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease. Am J Health Syst Pharm. 2010;67:728-33 pubmed publisher

Bhavsar J, Rosenson R. Adenosine transport, erythrocyte deformability and microvascular dysfunction: an unrecognized potential role for dipyridamole therapy. Clin Hemorheol Microcirc. 2010;44:193-205 pubmed publisher

Fourches D, Barnes J, Day N, Bradley P, Reed J, Tropsha A. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 2010;23:171-83 pubmed publisher

. Guide to Receptors and Channels (GRAC), 4th Edition. Br J Pharmacol. 2009;158 Suppl 1:S1-254 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Atterbury A, Wall M. Adenosine signalling at immature parallel fibre-Purkinje cell synapses in rat cerebellum. J Physiol. 2009;587:4497-508 pubmed publisher

Salcedo J, Kern M. Effects of caffeine and theophylline on coronary hyperemia induced by adenosine or dipyridamole. Catheter Cardiovasc Interv. 2009;74:598-605 pubmed publisher

Weyrich A, Skalabrin E, Kraiss L. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Am J Ther. 2009;16:164-70 pubmed publisher

Rouhl R, Lodder J. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?. Expert Rev Neurother. 2008;8:1661-5 pubmed publisher

Santana L, González Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008;51:6740-51 pubmed publisher

Chaturvedi S. Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention. Clin Ther. 2008;30:1196-205 pubmed

Pedersen J, Matsson P, Bergström C, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem. 2008;51:3275-87 pubmed publisher

Chakrabarti S, Freedman J. Dipyridamole, cerebrovascular disease, and the vasculature. Vascul Pharmacol. 2008;48:143-9 pubmed publisher

Kim H, Liao J. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008;28:s39-42 pubmed publisher

Zhang L, Yu J, Pan H, Hu P, Hao Y, Cai W, et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci U S A. 2007;104:19023-8 pubmed

Halkes P, Algra A. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?. Cerebrovasc Dis. 2007;24 Suppl 1:107-11 pubmed

Estebanez Perpina E, Arnold L, Arnold A, Nguyen P, Rodrigues E, Mar E, et al. A surface on the androgen receptor that allosterically regulates coactivator binding. Proc Natl Acad Sci U S A. 2007;104:16074-9 pubmed

Lin W, Buolamwini J. Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors. J Med Chem. 2007;50:3906-20 pubmed

De Schryver E, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev. 2007;:CD001820 pubmed

Sudlow C. Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA. BMJ. 2007;334:901 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

De Schryver E, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev. 2006;:CD001820 pubmed

Weyrich A, Kraiss L, Prescott S, Zimmerman G. New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates. Trends Cardiovasc Med. 2006;16:75-80 pubmed

Manallack D, Hughes R, Thompson P. The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases. J Med Chem. 2005;48:3449-62 pubmed

Cianchetta G, Singleton R, Zhang M, Wildgoose M, Giesing D, Fravolini A, et al. A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. J Med Chem. 2005;48:2927-35 pubmed

Denis D, Riendeau D. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. Eur J Pharmacol. 1999;367:343-50 pubmed

Hejna M, Raderer M, Zielinski C. Inhibition of metastases by anticoagulants. J Natl Cancer Inst. 1999;91:22-36 pubmed

Hanson K, Ziegler J, Rybalkin S, Miller J, Abman S, Clarke W. Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. Am J Physiol. 1998;275:L931-41 pubmed publisher

Hogan Y, Hawkins R, Alkadhi K. Adenosine A1 receptor activation inhibits LTP in sympathetic ganglia. Brain Res. 1998;807:19-28 pubmed

Sundaram M, Yao S, Ng A, Griffiths M, Cass C, Baldwin S, et al. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem. 1998;273:21519-25 pubmed

Goldberg B, Rattendi D, Lloyd D, Sufrin J, Bacchi C. Effects of intermediates of methionine metabolism and nucleoside analogs on S-adenosylmethionine transport by Trypanosoma brucei brucei and a drug-resistant Trypanosoma brucei rhodesiense. Biochem Pharmacol. 1998;56:95-103 pubmed

Thorn J, Jarvis S. Adenosine transporters. Gen Pharmacol. 1996;27:613-20 pubmed